|
AU2903999A
(en)
*
|
1998-03-12 |
1999-09-27 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
|
|
CN1635876A
(zh)
|
2000-02-04 |
2005-07-06 |
杜克大学 |
人免疫缺陷病毒疫苗
|
|
WO2001083535A2
(en)
*
|
2000-05-02 |
2001-11-08 |
Simon Fraser University |
Polypeptides for use as a vaccine and/or treatment for hiv infection
|
|
AUPS065002A0
(en)
|
2002-02-20 |
2002-03-14 |
Immunaid Pty Ltd |
Strategy for retroviral immunotherapy
|
|
US20030228320A1
(en)
*
|
2000-08-18 |
2003-12-11 |
Ashdown Martin Leonard |
Retroviral immunotherapy
|
|
US7754676B2
(en)
|
2000-09-15 |
2010-07-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Defensin-antigen fusion proteins
|
|
US7897152B2
(en)
|
2000-09-18 |
2011-03-01 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Viral chemokine-antigen fusion proteins
|
|
EP1361886A2
(en)
*
|
2001-02-15 |
2003-11-19 |
The Gov. of USA, as represented by the Secretary, Dept. of Health and Human services, National Institutes of Health |
Methods and compositions for inhibiting hiv-coreceptor interactions
|
|
AUPS054702A0
(en)
*
|
2002-02-14 |
2002-03-07 |
Immunaid Pty Ltd |
Cancer therapy
|
|
US7901690B2
(en)
*
|
2002-12-03 |
2011-03-08 |
University Of Massachusetts |
Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods
|
|
WO2004110384A2
(en)
*
|
2003-06-12 |
2004-12-23 |
Vaxgen, Inc. |
Hiv-1 envelope glycoproteins having unusual disulfide structure
|
|
US8076060B2
(en)
*
|
2003-08-04 |
2011-12-13 |
Emil William Chynn |
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
|
|
BRPI0415533A
(pt)
|
2003-10-24 |
2006-12-26 |
Immunaid Pty Ltd |
método de terapia
|
|
US20080248022A1
(en)
*
|
2004-09-08 |
2008-10-09 |
Immunaid Pty Ltd |
Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases
|
|
CA2577320C
(en)
*
|
2004-09-14 |
2019-08-13 |
Argos Therapeutics, Inc. |
Strain-independent amplification of pathogens and vaccines thereto
|
|
US8202523B2
(en)
*
|
2005-09-22 |
2012-06-19 |
ProSci, Inc. |
Glycosylated polypeptides produced in yeast mutants and methods of use thereof
|
|
WO2009017743A2
(en)
|
2007-07-30 |
2009-02-05 |
Argos Therapeutics, Inc. |
Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
|
|
JP5775451B2
(ja)
|
2008-06-19 |
2015-09-09 |
バリエーション バイオテクノロジーズ インコーポレイティド |
インフルエンザを処置するための組成物および方法
|
|
DK2435825T3
(en)
|
2009-05-27 |
2015-10-19 |
Biotempus Ltd |
Modes for medical care
|
|
MX2012000372A
(es)
|
2009-07-06 |
2012-02-28 |
Variation Biotechnologies Inc |
Metodos para preparar vesiculas y formulaciones producidas a partir de las mismas.
|
|
US9907746B2
(en)
|
2009-07-06 |
2018-03-06 |
Variation Biotechnologies, Inc. |
Methods for preparing vesicles and formulations produced therefrom
|
|
WO2011119920A2
(en)
|
2010-03-25 |
2011-09-29 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
|
CA2840079C
(en)
|
2010-07-06 |
2018-07-03 |
Variation Biotechnologies Inc. |
Compositions and methods for treating influenza
|
|
US10736844B2
(en)
|
2011-01-13 |
2020-08-11 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
ES2667425T3
(es)
|
2011-06-10 |
2018-05-10 |
Oregon Health & Science University |
Glucoproteínas y vectores recombinantes de CMV
|
|
AU2012216792A1
(en)
|
2011-09-12 |
2013-03-28 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
|
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
|
CA2894442C
(en)
|
2012-01-12 |
2020-01-21 |
Variation Biotechnologies Inc. |
Compositions and methods for treating viral infections
|
|
EP4008354A1
(en)
|
2012-01-27 |
2022-06-08 |
Variation Biotechnologies Inc. |
Methods and compositions for therapeutic agents
|
|
EP2679596B1
(en)
|
2012-06-27 |
2017-04-12 |
International Aids Vaccine Initiative |
HIV-1 env glycoprotein variant
|
|
CN104955847A
(zh)
|
2012-12-04 |
2015-09-30 |
马里兰州大学(巴尔的摩) |
HIV-1 Env结合抗体、融合蛋白及其使用方法
|
|
US20150065381A1
(en)
|
2013-09-05 |
2015-03-05 |
International Aids Vaccine Initiative |
Methods of identifying novel hiv-1 immunogens
|
|
EP2873423B1
(en)
|
2013-10-07 |
2017-05-31 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
|
US10174292B2
(en)
|
2015-03-20 |
2019-01-08 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
|
EP3072901A1
(en)
|
2015-03-23 |
2016-09-28 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|